TABLE 7.
Oxidation markers of LDL free cholesterol and triglyceride sub-fractions and apoB100 in CKD-5d patients under ± statin treatment.
O xidative marker | Patient group | Value | P-Value |
Cholesteryl ester-OOH | CKD-5dSt | 0.84 (±0.56) | 0.58 |
CKD-5dnoSt | 0.73 (±0.86) | ||
Triglyceride-OOH | CKD-5dSt | 1.34 (±0.91) | 0.34 |
CKD-5dnoSt | 1.62 (±1.11) | ||
Free cholesterol-OOH | CKD-5dSt | 0.34 (±0.25) | 0.54 |
CKD-5dnoSt | 0.43 (±0.39) | ||
Phospholipid-OOH | CKD-5dSt | 0.14 (±0.15) | 0.18 |
CKD-5dnoSt | 0.19 (±0.21) | ||
apoB100-MDA | CKD-5dSt | 17.00 (±5.99) | 0.1 |
CKD-5dnoSt | 15.00 (±5.92) | ||
apoB100-DiTyr | CKD-5dSt | 8.98 (±3.93) | 0.15 |
CKD-5dnoSt | 9.11 (±3.87) |
CKD-5d patients under statin/no statin treatment (CKD-5dSt/CKD-5dnoSt). Values are presented as mean (M) and standard deviation (SD). LDL sub-fraction-OOH marker is expressed as cum-OOH nmole equivalents/mg apoB100, apoB100-MDA marker as MDA pmole/mg apoB100, and apoB100-DiTyr marker as DiTyr pmole/mg apoB100.